Extrapiramidalismo por antieméticos
Resumen
Los antieméticos son usados frecuentemente por diversas áreas de la medicina, aunque existe una tendencia a subestimar sus efectos adversos neurológicos. El objetivo del presente estudio de revisión fue revisar la literatura sobre la fisiología, farmacología, factores predisponentes, clínica y manejo del extrapiramidalismo por antieméticos. Se realizó una búsqueda en la literatura de artículos de revistas científicas, libros y trabajos de grado. Se utilizaron los buscadores Medline, lilacs, PubMed, embase, Current contents y Google Scholar con las siguientes palabras claves: deshidratación, gastroenteritis, vómitos, antieméticos, distonía, dopamina, hipertermia, citocromo, metoclopramida y domperidona. Se obtuvieron 252 artículos, de los cuales 50 fueron considerados aptos para la revisión. A partir del análisis, se concluyó que el uso de antieméticos es de uso frecuente por medicina general y especialidades como anestesiología y pediatría, por lo cual un conocimiento sobre los efectos extrapiramidales permitirá un diagnóstico y manejo temprano.
Descargas
Referencias bibliográficas
Hendren G, Aponte-Feliciano A, Kovac A. Safety and efficacy of commonly used antiemetics. Expert Opin Drug Metab Toxicol. 2015;11(11):1753-67. DOI: 10.1517/17425255.2015.1080688.
Basch E, Prestrud A, Hesketh P, Kris M, Somerfield M, Lyman G. Antiemetic Use in Oncology: Updated Guideline Recommendations from ASCO. Am Soc Clin Oncol Educ Book. 2012:532-40. DOI: 10.14694/EdBook_AM.2012.32.532.
Black R, Morris S, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003:28;361(9376):2226-34. Doi: 10.1016/S0140-6736(03)13779-8.
King C, Glass R, Bresee J, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003:21;52(16):1-16.
Albano F, Bruzzese E, Spagnuolo M, De Marco G. Antiemetics for children with gastroenteritis: off-label but still on in clinical practice. J Pediatr Gastroenterol Nutr. 2006;43(3):402-4. doi: 10.1097/01.mpg.0000232571.56397.0d.
Kwon K, Rudkin S, Langdorf M. Antiemetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians. Clin Pediatr (Phila). 2002;41(9):641-52. doi: 10.1177/000992280204100902.
Stafford R. Regulating off-label drug use--rethinking the role of the FDA. N Engl J Med. 2008;3;358(14):1427-9. doi: 10.1056/NEJMp0802107.
Fedorowicz Z, Jagannath V, Carter B. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev. 2011:7;(9):CD005506. DOI: 10.1002/14651858.CD005506.pub5.
van Der Kleij F, de Vries P, Stassen PM, Sprenger HG, Gans RO. Acute dystonia due to metoclopramide: increased risk in AIDS. Arch Intern Med. 2002;11;162(3):358-9.
Contreras-Domínguez V, Carbonell-Bellolio P. Profilaxia antiemética em cirurgia de abdome agudo: estudo comparativo entre droperidol, metoclopramida, tropisetron, granisetron e dexametasona. Rev. Bras. Anestesiol. 2008;58(1):35-44. DOI: 10.1590/S0034-70942008000100005. (16)
Lau Moon Lin M, Robinson P, Flank J, Sung L, Dupuis L. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis. Drug Saf. 2016;39(7):675-87. DOI: 10.1007/s40264-016-0418-9.
Stamer U, Lehnen K, Höthker F, Bayerer B, Wolf S, Hoeft A, et al. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain. 2003;105(1-2):231-8.
Calderón-Flórez V, Machado-Duque M, Machado-Alba J. Perfil de uso y seguridad de metoclopramida en pacientes pediátricos atendidos en un hospital de segundo nivel. Rev CES Med 2016;30(1):35-45.
Sanchez J. Efectos extrapiramidales por metoclopramida en embarazo y recien nacido. Revista Salud Bosque. 2015;5(1):63-66.
Moos D, Hansen D. Metoclopramide and extrapyramidal symptoms: a case report. J Perianesth Nurs. 2008;23(5):292-9. DOI: 10.1016/j.jopan.2008.07.006.
Rodgers C. Extrapyramidal side effects of antiemetics presenting as psychiatric illness. Gen Hosp Psychiatry. 1992;14(3):192-5.
Tianyi F, Agbor V, Njim T. Metoclopramide induced acute dystonic reaction: a case report. BMC Res Notes. 2017:7;10(1):32. DOI: 10.1186/s13104-016-2342-6.
Breeden R, Ford H, Chrisman C, Mascioli C. Neuroleptic Malignant Syndrome Secondary to Metoclopramide Use in an Elderly Gastroenterologic Surgery Patient. Gastroenterol Nurs. 2017;40(2):93-100. DOI: 10.1097/SGA.0000000000000173.
Kocyigit S, Soysal P, Isik AT. Neuroleptic malignant syndrome associated with only one dose of metoclopramide in an older adult. Geriatr Gerontol Int. 2017;17(8):1232-1233. DOI: 10.1111/ggi.13044.
Wittmann O, Sadot E, Bisker-Kassif O, Scolnik D, Tavor O, Glatstein M. Neuroleptic Malignant Syndrome Associated With Metoclopramide Use in a Boy: Case Report and Review of the Literature. Am J Ther. 2016;23(5):e1246-9. DOI: 10.1097/MJT.0000000000000320.
Doggrell S, Hancox J. Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine. xpert Opin Drug Saf. 2014;13(1):131-8. DOI: 10.1517/14740338.2014.851193.
Roy-Desruisseaux J, Landry J, Bocti C, Tessier D, Hottin P, Trudel J. Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. Ann Pharmacother. 2011;45(9):e51. DOI: 10.1345/aph.1Q214.
Henzi I, Walder B, Tramèr M. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000;90(1):186-94.
Perron G, Dolbec P, Germain J, Béchard P. Perineal pruritus after i.v. dexamethasone administration. Can J Anaesth. 2003;50(7):749-50. DOI: 10.1007/BF03018722.
Gupta P, Jain S. Postoperative nausea and vomiting prophylaxis: A comparative study of ondansetron, granisetron and granisetron and dexamethasone combination after modified radical mastectomy.Saudi J Anaesth. 2014;8(Suppl 1):S67-71. DOI: 10.4103/1658-354X.144081.
Hsu E. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010;17(5):476-86. DOI: 10.1097/MJT.0b013e3181ea7821.
Kumar N, Hu W. Extrapyramidal reaction to ondansetron and propofol. Mov Disord. 2009;30;24(2):312-3. DOI: 10.1002/mds.22367.
Patel A, Mittal S, Manchanda S, Puliyel J. Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. Ann Pharmacother.2011;45(1):e7. DOI: 10.1345/aph.1P332.
Spiegel J, Kang V, Kunze L, Hess P. Ondansetron-induced extrapyramidal symptoms during cesarean section. Int J Obstet Anesth. 2005;14(4):368-9.DOI: 10.1016/j.ijoa.2005.06.001
Alhashimi D, Alhashimi H, Fedorowicz Z. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev. 2006;19:(3):CD005506. DOI: 10.1002/14651858.CD005506.pub2.
Caroff S, Campbell E. Drug-Induced Extrapyramidal Syndromes: Implications for Contemporary Practice. Psychiatr Clin North Am. 2016;39(3):391-411. DOI: 10.1016/j.psc.2016.04.003.
Dayalu P, Chou K. Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opin Pharmacother. 2008;9(9):1451-62. DOI: 10.1517/14656566.9.9.1451.
D'Souza R, Mercogliano C, Ojukwu E, D'Souza S, Singles A, Modi J, Short A, Donato A. Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis.Emerg Med J. 2018;35(5):325-331. DOI: 10.1136/emermed-2017-206944.
Sherer J, Salazar T, Schesing K, McPartland S, Kornitzer J. Diphenhydramine for Acute Extrapyramidal Symptoms After Propofol Administration. Pediatrics. 2017;139(2).pii:e20161135. DOI: 10.1542/peds.2016-1135.
Rao A, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31(1):11-9. DOI: 10.1111/j.1365-2036.2009.04189.x.
Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008;48(3):379-84. DOI: 10.1177/0091270007312258.
Mejia N, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005;20(1):86-9. DOI: 10.1002/mds.20259.
Matson J, Mayville E, Bielecki J, Smalls Y, Eckholdt CS. Tardive dyskinesia associated with metoclopramide in persons with developmental disabilities. Res Dev Disabil. 2002;23(3):224-33.
Lai T, Seeman P, Liu F. Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia. Synapse. 2012;66(3):273-6. DOI: 10.1002/syn.21504.
Karimi Khaledi M, Suda K, Shelton C. Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent. Int J Clin Pharm. 2012;34(6):822-4. DOI: 10.1007/s11096-012-9685-4.
Ehrenpreis E, Deepak P, Sifuentes H, Devi R, Du H, Leikin J. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol. 2013;108(6):866-72. DOI: 10.1038/ajg.2012.300.
Wijemanne S, Jankovic J, Evans R. Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine. Headache. 2016;56(1):153-61. DOI: 10.1111/head.12712.
Tibaduiza Y. Rabdomiólisis en la primera semana de entrenamiento. Reporte de dos casos. Revista Med. 2015; 23(2):96-109.
Guru S, Vanamoorthy U, Loganathan S, Varghese M. Neuroleptic malignant syndrome following abrupt anti-cholinergic withdrawal: a case report. Asian J Psychiatr. 2014;12:158-9. DOI: 10.1016/j.ajp.2014.05.007.
Dosi R, Ambaliya A, Joshi H, Patell R. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ Case Rep. 201;23;2014.pii: bcr2014204154. DOI: 10.1136/bcr-2014-204154.
Zou D, Shao Y, Qin Z, Zhang J, Liu N, Li Z, et al. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. Forensic Leg Med. 2014;24:12-4. DOI: 10.1016/j.jflm.2014.02.011.
Trollor J, Chen X, Sachdev P. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23(6):477-92. DOI: 10.2165/00023210-200923060-00003
Reilly T, Kirk M. Atypical antipsychotics and newer antidepressants. Emerg Med Clin North Am. 2007;25(2):477-97. DOI: 10.1016/j.emc.2007.02.003.
Susman V. Clinical management of neuroleptic malignant syndrome. Psychiatr Q. 2001;72(4):325-36.
Strawn J, Keck P, Caroff S. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164(6):870-6. DOI: 10.1176/ajp.2007.164.6.870
.png)
